Nexien BioPharma
(OTC) NXEN
Nexien BioPharma Financials at a Glance
Market Cap
$7,100
Revenue (TTM)
$0.00
Net Income (TTM)
$188.08K
EPS (TTM)
$-0.00
P/E Ratio
-0.04
Dividend
$0.00
Beta (Volatility)
-2.01 (Low)
Dividend
$0.00
Beta (Volatility)
-2.01 (Low)
Price
$0.00
Volume
104,600
Open
$0.00
Price
$0.00
Volume
104,600
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.01
Dividend
$0.00
Beta (Volatility)
-2.01 (Low)
Price
$0.00
Volume
104,600
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.01
NXEN News
NXEN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Nexien BioPharma
Industry
Pharmaceuticals
Sector
Health CareCEO
Richard Greenberg
Website
www.nexienbiopharma.comHeadquarters
Glendale, CO 80246, US
NXEN Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
12%
Return on Assets
-12%
Earnings Yield
-25.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$7.10K
Shares Outstanding
70.77M
Volume
104.60K
Short Interest
0.00%
Avg. Volume
5.08K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$156.00K
EBITDA
$337.00
Operating Cash Flow
$64.36K
Capital Expenditure
$4.00
Free Cash Flow
$64.36K
Cash & ST Invst.
$4.18K
Total Debt
$312.25K
Nexien BioPharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$7.10K
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$30.09K
+43.4%
EBITDA
$0.00
N/A
Quarterly Fundamentals
Net Cash
$367.09K
-28.8%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$375.38K
+27.2%
Return on Assets
-12.26%
N/A
Return on Invested Capital
11.99%
N/A
Free Cash Flow
$13.02K
+37.9%
Operating Cash Flow
$13.02K
+37.9%